300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Photography
Crowdfunding
Financial Services
Construction
Mobile
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Digital Media
Marketplace
Retail
Film
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Real Estate
Mobile Apps
Finance
Manufacturing
FinTech
Social Media
Franchise
Sporting Goods
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Music
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
China
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Shanghai STVC Group, VC Fund

Shanghai STVC Group

VC Fund

Shanghai, China

Shanghai STVC Group is a VC fund in Shanghai focused on Manufacturing and Health Care. Shanghai Science and Technology Venture Capital (Group) Co., Ltd. was formally inaugurated by Shanghai Science and Technology Investment Corporation and Shanghai Venture Capital Co., Ltd. through strategic restructuring. After the reorganization, the registered capital of Science and Technology Group was 1.69 billion yuan, and the directly managedfunds amounted to 12 billion yuan. Directly supervised by the Shanghai State-owned Assets Supervision and Administration Commission, the company is one of the largest state-owned venture capital institutions in Shanghai and even the whole country, and shoulders the mission of promoting the construction of Shanghai's globally influential science and technology innovation center.

Total investments:
29
Last investment:
Lead investor:
24%

Last updated:

Industries Shanghai STVC Group invests in

ManufacturingHealth CareSemiconductorMedicalBiotechnology

Stages Shanghai STVC Group invests in

Series BSeedSeries ASeries CVenture - Series Unknown

Countries Shanghai STVC Group invests in

China

Contacts

NameEmailPhoneSocials
Weiguo Chen Weiguo Chen

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Manufacturing 8 (28%)
  • Health Care 6 (21%)
  • Semiconductor 6 (21%)
  • Medical 5 (17%)
  • Biotechnology 5 (17%)
See all 36 industries →

Stage

  • Series B 9 (31%)
  • Seed 5 (17%)
  • Series A 5 (17%)
  • Series C 5 (17%)
  • Venture - Series Unknown 2 (7%)
See all 8 stages →

Team

NameTitleInvestmentsLinksEmail
Weiguo Chen
Weiguo Chen General Manager, Executive Director
General Manager, Executive Director Total investments: 0 Find email

Investments

CompanyDescriptionRoundLinks
New Radiomedicine Technology New Radiomedicine Technology
Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting.In April 2016, the company was founded bythree co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy.The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China. $145.4M / Series E / Apr 03, 2026
Matrixtime Robotics Matrixtime Robotics
Matrixtime is an AI technology start-up. Based on deep learning, it is committed to the development of complex machine vision and industrial robot AI system products, empowering high-end manufacturing and providing scene-oriented industrial AI products. From high-end semiconductor manufacturing into complex machine vision inspection, Matrixtime hascovered scenarios including advanced semiconductor manufacturing, photovoltaic energy, automotive precision manufacturing, and unmanned ports. Series B / Oct 20, 2025
Contemporary Amperex Intelligence Technology Contemporary Amperex Intelligence Technology
Contemporary Amperex Intelligence Technology (Shanghai) Limited (CAIT-SH) is focused on the development of the CATL Integrated Intelligent Chassis (CIIC) project, which incorporates a battery, electric drive, and Cell-to-Chassis (CTC) technology. $280.7M / Oct 10, 2025
Contemporary Amperex Intelligence Technology Contemporary Amperex Intelligence Technology
Contemporary Amperex Intelligence Technology (Shanghai) Limited (CAIT-SH) is focused on the development of the CATL Integrated Intelligent Chassis (CIIC) project, which incorporates a battery, electric drive, and Cell-to-Chassis (CTC) technology. $278.6M / Series A / Jul 28, 2025
Zhixin Haozheng Zhixin Haozheng
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes. $13.7M / Series A / May 06, 2025
Noematrix Noematrix
Noematrix is an embodied intelligence company that specializes in innovative general robotic intelligence solutions and services. Seed / Apr 10, 2025
Photoacoustic Pharmaceuticals Photoacoustic Pharmaceuticals
Photoacoustic Pharmaceuticals is an innovative developer of photosensitizers and related products. It is committed to advancing the development of dynamic photoacoustic therapy. Series A / Nov 26, 2024
Prospective Innovation Institute Prospective Innovation Institute
The Prospective Innovation Institute is a technological achievement transformation service provider dedicated to the development of forward-thinking, disruptive, and unique technologies, as well as the organization of collaborative research on essential technologies. $698.4K / Venture - Series Unknown / Aug 02, 2024
Baoji Pharmaceutical Baoji Pharmaceutical
Baoji Pharmaceutical is a biopharma R&D manufacturer, a Sino-foreign joint biopharmaceutical enterprise integrating drug R&D and production. Series C / Jul 19, 2024
Huaxuan Sensing Huaxuan Sensing
Huaxuan Sensing is a sensor technology company that focuses on the development of resolver sensors for the new energy automobile industry. Series B / Jun 05, 2024
See all 29 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Photography
Crowdfunding
Financial Services
Construction
Mobile
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Digital Media
Marketplace
Retail
Film
Payments
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
B2B
Social Network
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Blockchain
Software
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Real Estate
Mobile Apps
Finance
Manufacturing
FinTech
Social Media
Franchise
Sporting Goods
Internet
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Music
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Burkina Faso
Africa
LATAM
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Oman
Puerto Rico
Poland
Colombia
Guernsey
Cameroon
China
Armenia
Côte d'Ivoire
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Morocco
Australia
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
New Zealand
Seychelles
Botswana
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Bangladesh
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Jersey
Estonia
Bolivia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Liechtenstein
Iceland
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Shanghai STVC Group invest in?

Shanghai STVC Group invests primarily in Manufacturing, Health Care and Semiconductor startups, most often at Series B and Seed stage. Most of the 29 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Shanghai STVC Group?

Public channels for Shanghai STVC Group include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Shanghai STVC Group?

The team at Shanghai STVC Group includes Weiguo Chen (General Manager, Executive Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Shanghai STVC Group Shanghai STVC Group Find emails